In a filing, Nuvalent Inc revealed its President and CEO Porter James Richard unloaded Company’s shares for reported $2.08 million on Jun 16 ’25. In the deal valued at $76.93 per share,27,000 shares were sold. As a result of this transaction, Porter James Richard now holds 249,062 shares worth roughly $19.15 million.
Then, Pelish Henry E. sold 200 shares, generating $15,964 in total proceeds. Upon selling the shares at $79.82, the Chief Scientific Officer now owns 63,101 shares.
Before that, HENRY E PELISH bought 22,000 shares. Nuvalent Inc shares valued at $1,717,980 were divested by the Officer at a price of $78.09 per share.
UBS upgraded its Nuvalent Inc [NUVL] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late December with a ‘”a Buy”‘ rating. UBS began covering NUVL with “Neutral” recommendation on October 24, 2024. Barclays started covering the stock on August 29, 2024. It rated NUVL as “an Overweight”.
Price Performance Review of NUVL
On Tuesday, Nuvalent Inc [NASDAQ:NUVL] saw its stock jump 1.18% to $76.88. Over the last five days, the stock has gained 0.73%. Nuvalent Inc shares have fallen nearly -1.94% since the year began. Nevertheless, the stocks have fallen -1.79% over the past one year. While a 52-week high of $113.51 was reached on 02/06/25, a 52-week low of $55.53 was recorded on 04/09/25.
Levels Of Support And Resistance For NUVL Stock
The 24-hour chart illustrates a support level at 75.41, which if violated will result in even more drops to 73.93. On the upside, there is a resistance level at 77.76. A further resistance level may holdings at 78.64.
How much short interest is there in Nuvalent Inc?
A steep rise in short interest was recorded in Nuvalent Inc stocks on 2025-05-30, dropping by -0.44 million shares to a total of 5.63 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 6.06 million shares. There was a decline of -7.8%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 17, 2024 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $97 price target.
